Physician profile
Kyle A Batton
NPI 1386105088
$5,600.45
in general payments reported to CMS, 2019-2025
21 companies · $3,367 in 2025
The $3,367 reported for 2025 was more than what 87% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $39.78 · 2024: $2,194 · 2025: $3,367.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,586 · Travel and Lodging: $14.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,586.19 |
| Travel and Lodging | $14.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,358.50 | 2024-2025 | General - Pain Management, Wavewriter Alpha Prime 16, Intracept |
| Abbott Laboratories | $844.76 | 2024-2025 | Proclaim, Eterna |
| Globus Medical, INC. | $722.90 | 2025 | Senza |
| Collegium Pharmaceutical, INC. | $452.29 | 2024-2025 | Xtampza |
| Spr Therapeutics, INC | $451.56 | 2024-2025 | Sprint Pns System |
| Nevro Corp. | $331.99 | 2024 | Senza |
| Medtronic, INC. | $312.02 | 2025 | Intellis Adaptivestim |
| Spinal Simplicity, LLC | $298.36 | 2024-2025 | Ha Minuteman G3-R |
| Biotronik Nro, INC. | $209.17 | 2025 | Prospera |
| Averitas Pharma INC. | $111.62 | 2023-2025 | Qutenza |
| Valinor Pharma, LLC | $98.47 | 2025 | Movantik |
| Nalu Medical, INC. | $97.97 | 2024-2025 | Nalu Neurostimulation System |
| Depuy Synthes Sales INC. | $76.79 | 2024-2025 | Orthovisc, Monovisc |
| Curonix LLC | $63.76 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Saluda Medical Americas, INC. | $42.97 | 2025 | Evoke |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $29.94 | 2025 | |
| Vertos Medical, INC. | $28.61 | 2024 | Mild Device Kit |
| Mml US, INC. | $25.63 | 2025 | Reactiv8 |
| Bioventus LLC | $14.59 | 2025 | Gelsyn-3 |
| Protega Pharmaceutials INC | $14.29 | 2025 | Roxybond |
| Abiomed | $14.26 | 2023 | Impella |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Batton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.